Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma

Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma

ScrippsHealth

4 years
240 Views
Share Report
Want to watch this again later?
Sign in to add this video to a playlist. Login
0 0
Category:
Description:
Morie A. Gertz, MD of Mayo Clinic discusses Panobinostat and other HDAC inhibitors in relapsed Multiple Myeloma at Scripps Health 36th Annual Conference: Clinical Hematology and Oncology in San Diego.
Up Next Autoplay